Nitorum Capital, L.P. Mannkind Corp Transaction History
Nitorum Capital, L.P.
- $941 Million
- Q1 2024
A detailed history of Nitorum Capital, L.P. transactions in Mannkind Corp stock. As of the latest transaction made, Nitorum Capital, L.P. holds 10,079,558 shares of MNKD stock, worth $52.6 Million. This represents 4.85% of its overall portfolio holdings.
Number of Shares
10,079,558
Previous 10,831,390
6.94%
Holding current value
$52.6 Million
Previous $39.4 Million
15.81%
% of portfolio
4.85%
Previous 4.36%
Shares
4 transactions
Others Institutions Holding MNKD
# of Institutions
209Shares Held
130MCall Options Held
1.81MPut Options Held
808K-
Black Rock Inc. New York, NY21.6MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$79 Million0.0% of portfolio
-
State Street Corp Boston, MA11.9MShares$62.3 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY9MShares$47 Million0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA6.03MShares$31.5 Million0.0% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.34B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...